首页> 外文期刊>Science China Life Sciences >Advances in preimplantation genetic diagnosis/screening
【24h】

Advances in preimplantation genetic diagnosis/screening

机译:植入前遗传学诊断/筛查的进展

获取原文
       

摘要

Preimplantation genetic diagnosis (PGD) gives couples who have a high risk of transmitting genetic disorders to their baby the chance to have a healthy offspring through embryo genetic analysis and selection. Preimplantation genetic screening (PGS) is an effective method to select euploid embryos that may prevent repeated implantation failure or miscarriage. However, how and to whom PGS should be provided is a controversial topic. The first successful case of PGD of a human being was reported in 1990, and there have been tremendous improvements in this technology since then. Both embryo biopsy and genetic technologies have been improved dramatically, which increase the accuracy and expand the indications of PGD/PGS.
机译:植入前遗传学诊断(PGD)通过胚胎遗传学分析和选择,为那些将遗传性疾病传播给婴儿的高风险夫妇提供了一个拥有健康后代的机会。植入前遗传筛选(PGS)是一种选择整倍体胚胎的有效方法,可以防止重复植入失败或流产。但是,如何以及向谁提供PGS是一个有争议的话题。 1990年报道了首例成功的人类PGD病例,此后该技术有了巨大的进步。胚胎活检和遗传技术均得到了极大的改进,从而提高了准确性并扩大了PGD / PGS的适应症。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号